HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 281 filers reported holding HAEMONETICS CORP in Q4 2018. The put-call ratio across all filers is 2.89 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BEACONLIGHT CAPITAL, LLC | 95,033 | $8,511,000 | 2.84% |
| Advantage Alpha Capital Partners LP | 100,170 | $8,971,000 | 2.10% |
| Nitorum Capital, L.P. | 395,635 | $35,433,000 | 1.82% |
| Summit Creek Advisors LLC | 127,600 | $11,428,000 | 1.68% |
| Bridge City Capital, LLC | 40,559 | $3,632,000 | 1.67% |
| AEGON ASSET MANAGEMENT UK PLC | 520,408 | $46,603,000 | 1.05% |
| Jackson Square Partners, LLC | 2,298,190 | $205,825,000 | 1.03% |
| Parkman Healthcare Partners LLC | 30,147 | $2,700,000 | 0.76% |
| TEALWOOD ASSET MANAGEMENT INC | 9,154 | $820,000 | 0.54% |
| AMERICAN CAPITAL MANAGEMENT INC | 159,145 | $14,253,000 | 0.52% |